Evidence map›Paper›PMID 32173274›Full record

ArticleThe International journal on drug policy2020

"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.

Emma L Richard, Christine A Schalkoff, Hannah M Piscalko, Daniel L Brook, Adams L Sibley, Kathryn E Lancaster, William C Miller, Vivian F Go

Abstract read
In one paragraph

Article in The International journal on drug policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Examining geographic disparities in access to no-cost naloxone in North Carolina: A cross-sectional survey of naloxone distribution programs.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Expanding the opioid use disorder medication treatment workforce in rural communities through the RCORP initiative.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emma L RichardDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA. Electronic address: emrichar@montefiore.org.
Christine A SchalkoffDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Hannah M PiscalkoDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Daniel L BrookDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Adams L SibleyDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kathryn E LancasterDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
William C MillerDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Vivian F GoDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Funding

Learning from the COVID-19 pandemic to improve emergency management planning for harm reduction services in rural OhioUH3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2019 to 2022
$2.5M
Implementing a Community-Based Response to the Opioid Epidemic in Rural OhioUG3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2017 to 2018
$1.1M
NIDA NIH HHS UG3 DA044822NIDA NIH HHS UH3 DA044822
6 · The paper itself

Abstract

backgroundMedication-assisted treatment (MAT) is an evidence-based strategy to treat opioid use disorder (OUD). However, MAT-related stigma reduces MAT uptake, which is particularly low in rural areas. To date, perceptions and attitudes towards MAT in rural settings have not been described.

objectiveThis qualitative study aims to characterize perceptions and attitudes towards MAT and the environmental factors contributing to these views in Appalachian Ohio.

methodsFrom February to July 2018, semi-structured interviews were conducted with 34 stakeholders (12 healthcare professionals, 12 substance use treatment providers, 7 law enforcement agents and judicial officials, and 3 members of relevant organizations) in three rural counties in Appalachian Ohio. Interviews were transcribed, coded, and analyzed to characterize the risk environment and participants' perceptions and attitudes towards MAT.

resultsParticipants expressed or described pervasive MAT-related stigma in the region. Participants consistently described three elements of the environment affecting stigma: (1) a "conservative" culture in which abstinence is necessary to be in recovery successfully, (2) fear of medication diversion and abuse, and (3) drug court policies that keep MAT out of the criminal justice system.

conclusionMAT-related stigma will need to be addressed to tackle the opioid epidemic through evidence-based treatment effectively.

Indexed as

Opioid-Related DisordersAppalachian RegionHumansOhioPerceptionRural PopulationAppalachiaMedication-assisted treatmentOpioid use disorderRisk environmentRuralStigma

Identifiers

PMID32173274
PMCPMC8018539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.